ClearanceBrief
Recall Z-0322-2027 ยท PFF High Throughput Dna Sequence Analyzer

Illumina, Inc.

NovaSeq 6000Dx Instrument REF: 20068232, FOR IN VITRO DIAGNOSTIC USE

DateOct 30, 2026 (initiated May 8, 2024)
StatusOpen, Classified
Reason(Retrospectively reported) Cybersecurity vulnerability identified in communication protocol between the customer-provided infrastructure (network storage, servers, or computers) and in vitro diagnostic devices which may result in compromised data transmission.
Root causeLabeling design
ActionOn May 8, 2024, Illumina, Inc. issued a Urgent Medical Device Recall via email. Illumina ask consignees to take the following 1. Download & read this Cybersecurity Guidance document. The full hyperlink is below. https://support.illumina.com/support-content/cyberguidance.html 2. For Each Product Connected to the Customer Network: work with your internal IT department to determine which secure protocol works best in your environment and to implement the appropriate configuration change. Note: a change to the network protocol affects both Dx and RUO modes simultaneously therefore there is no n
Quantity41 units
DistributionWorldwide - US Nationwide distribution including in the states and territory of AL, AR, AZ, CA, CO, CT, DC, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NH, NJ, NM, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV and the countries of AE, AR, AT, AU,
FDA recordOpen on fda.gov

510(k) clearances named in this recall

This recall record lists no 510(k) number.